It’s hard to justify holding a junior miner that’s falling right now. Aurion Resources (Toronto Venture: AU) made a heroic recovery from its March low, but we are still down. In a market where gold, silver and copper prices are...
Read MoreIf you listened to the weekly podcast yesterday, I gave you a heads-up about today’s actions. It’s time to sell The Valens Company (Toronto: VLNS) and Alcanna Inc. (Toronto: CLIQ). Our optimism for these junior cannabis stocks...
Read MoreOur optimistic outlook for Medipharm Labs (Toronto: LABS) turned sour after the company reported earnings. The COVID-19 pandemic has taken a huge toll on many companies. But Medipharm’s troubles are also located up the chain of...
Read MoreOne of our principal goals for any Front Line Profits recommendation is its ability to double our money in the first 12 months of the position. That doesn’t always happen, but it’s our goal. Right at the start, we said Gensource...
Read MoreAccount Log in Welcome! Log in to access your Research Services. Did you forget your password? Email Address Next Change email address Password Remember...
Read More
Director of VIP Services
Research Analyst
CEO of Banyan Hill
Editor of Alpha Investor
Chief Investment Strategist of Money & Markets
Editor of Precision Profits and Apex Alert
Editor of Strategic Fortunes and three elite services
Director of Investment Research